Posted by Michael Wonder on 13 May 2018
President promises to attack high drug prices
12 May 2018 - But plan does not call for allowing Medicare to negotiate medicine costs.
“AARP is encouraged that the president is focusing attention on lowering prescription drug prices,” says Nancy LeaMond, AARP’s executive vice president and chief advocacy and engagement officer. “High-priced drugs hurt everyone, and seniors, who on average takes 4.5 medications a month, are particularly vulnerable.”
LeaMond says that AARP welcomes “a broad look across the entire drug supply chain to find ways to help drive down drug prices.” AARP also urges the safe importation of lower-priced drugs and greater transparency in prescription drug pricing.
“AARP also strongly believes that it is critical that any proposals to lower prescription drug costs don’t simply shift the costs around in the health care system without addressing the root problem: the prices set by pharmaceutical companies, says LeaMond.
